Advertisement
UK markets close in 40 minutes

  • FTSE 100

    8,143.49
    +64.63 (+0.80%)
     

  • FTSE 250

    19,830.69
    +228.71 (+1.17%)
     

  • AIM

    756.03
    +2.91 (+0.39%)
     

  • GBP/EUR

    1.1666
    +0.0009 (+0.08%)
     

  • GBP/USD

    1.2473
    -0.0037 (-0.30%)
     

  • Bitcoin GBP

    51,267.38
    +440.12 (+0.87%)
     

  • CMC Crypto 200

    1,340.49
    -56.04 (-4.01%)
     

  • S&P 500

    5,099.96
    +51.54 (+1.02%)
     

  • DOW

    38,191.10
    +105.30 (+0.28%)
     

  • CRUDE OIL

    83.41
    -0.16 (-0.19%)
     

  • GOLD FUTURES

    2,344.40
    +1.90 (+0.08%)
     

  • NIKKEI 225

    37,934.76
    +306.28 (+0.81%)
     

  • HANG SENG

    17,651.15
    +366.61 (+2.12%)
     

  • DAX

    18,191.53
    +274.25 (+1.53%)
     

  • CAC 40

    8,110.79
    +94.14 (+1.17%)
     
PROPERTY:

9 luxury homes to consider if money is no object

Ever thought about what a multimillion pound budget would buy you?

Want to Grow Richer? These Stocks Have Doubled in the Past 5 Years

Kody Kester, The Motley Fool
·3-min read
Want to Grow Richer? These Stocks Have Doubled in the Past 5 Years

Shares of AstraZeneca (NASDAQ: AZN) and Merck (NYSE: MRK) have both more than doubled over the last five years. With a $228 billion market capitalization, AstraZeneca is the sixth-largest pharmaceutical company in the world and the second-biggest international-based drugmaker behind Novartis (NYSE: NVS). As you'd guess would be the case for a major player in the pharmaceutical industry, the British drugmaker possesses a remarkable product portfolio.

Continue reading